Cov txheej txheem
2. {{{2 - pyrrolidone - 1 -} QHIA RAU VINL POLYRANERS
3.Technology Frontier: Txoj kev los txhim kho biocompatibility
4.Yog ntsuam xyuas: Cov peev xwm muaj peev xwm thiab kev daws teeb meem
5. Ntxuav cov ntawv thov: Kev tswjfwm tshiab hauv cov cuab yeej kho mob thiab cov neeg nqa tshuaj
6..NEDUTENYURE TXUAG: Kev coj kev cai txoj cai thiab kev sib xyaw thev naus laus zis

Nrog rau kev loj hlob sai ntawm biomedical thev naus laus zis, cov khoom tshiab tau siv nyob rau hauv daim teb no. Raws li cov khoom siv polymer nrog cov khoom ntiag tug, 2- pyrrolidone {}} yas} yas} yas} Vinyl Polymer tau pom cov ntawv thov zoo hauv kev kho cov ntawv biomedical. Txawm li cas los xij, nws biocompatibility thiab biosafety teeb meem tau dhau los ua qhov tseem ceeb txwv nws txoj kev loj hlob ntxiv thiab kev thov. Kab lus no yuav tshawb txog qhov tob yuav ua li cas txhim kho biocompatibility ntawm{{0 {0}} pyrrolidone -1- yas vinyl polymerHauv kev siv biomedical, nrog rau txheeb xyuas tau cov teeb meem biosafety.
2. {{{2 - pyrrolidone - 1 -} QHIA RAU VINL POLYRANERS
2- pyrrolidone -1- vinyl polymer yog cov tshuaj tiv thaiv polymerization siab. Nws muaj cov solubility zoo, ua yeeb yaj kiab ua yeeb yam thiab qee yam khoom siv neeg. Nws cov qauv molecular muaj cov pab pawg pyrrolidone thiab yas ntu. This unique structure gives it some special physical and chemical properties, making it have potential application value in biomedical fields such as drug delivery, tissue engineering, and biosensors.
3.Technology Frontier: Txoj kev los txhim kho biocompatibility
1. Innovation nyob rau hauv molecular qauv hloov kho
Los ntawm kev tswj hwm cov copolymerization piv ntawm Vinyl pyrrolidone (N-VP) thiab Divinylenic-Liplophilic tshuav nyiaj li cas. Cov kev tshawb fawb tau qhia tias thaum tus nqi HLB yog tswj hwm nyob rau hauv thaj tsam ntawm {2}}}, cov polymer tseem ceeb txo cov qe ntshav thaum tswj cov tshuaj muaj peev xwm thauj khoom.
Cov tshiab khiv tsim lub hnub qub-puab nce mus rau saum npoo Zeta muaj peev xwm ntawm cov khoom siv los ntawm {1} Txo cov phagocytic tus nqi ntawm macrophages. Hauv cov kev sim vitro qhia tau tias lub sijhawm ua haujlwm ntawm cov khoom siv hloov pauv hauv cov khoom sib xyaw hauv cov khoom sib txawv tau txuas mus rau 3.2 lub sijhawm ntawm cov khoom lag luam.
2. Kev vam meej hauv kev txhim kho cov khoom siv sib xyaw
Polyvinyl pyrrolidone (PVP) thiab Chitosan form ib qho kev cuam tshuam nrog cov qauv network, uas tuaj yeem txhim kho cov tshuab ua kom muaj zog thiab biodegradity ntawm cov khoom. Tsiaj sim ua yeeb yam hais tias kev zais cia ntawm cov khoom siv tsis zoo yog 67% qis dua li cov duab ntshiab pvp, thaum lub vascular endothelial kev loj hlob endothelial kev loj hlob endothelial loj hlob ntawm 42%.
Graphene \/ PVP Composite coj cov khoom tawg los ntawm kev txwv tsis pub muaj txog 35 s \/ cm thiab impedance muaj txiaj ntsig ob qho kev sib luag ntawm qis dua li ntawm kev kho mob silicone. Cov ntaub ntawv no muaj qhov zoo nyob hauv thaj teb ntawm cov hluav taws xob neural, thiab tswj cov teeb liab ruaj ntseg tsim tau ua tau rau lub hlis tom qab cog hniav.
4.Yog ntsuam xyuas: Cov peev xwm muaj peev xwm thiab kev daws teeb meem
1. Hauv Vivo metabolic txheej txheem kev kawm
Although PVP has excellent physiological inertness, polymers with a molecular weight of >50 KDA yuav tuaj yeem khaws cia los ntawm cov kev ua kom rov ua haujlwm. Cov ntawv tshaj tawm tsis ntev los no luam tawm nyob rau hauv Biomaterials tau taw qhia tias kev siv xov tooj cua ntawm lub siab pvp ntau dua ntawm daim siab rau ntau tshaj 180 hnub.
Kev daws:
(1.) Tsim ib qho kev tswj hwm tsis tau tshwm sim hla kev sib txuas lus
(2.) Qhia enzyme-resp-compar-breaking pawg
(3.) ua kom zoo cov molecular hnyav tswj kev tswj hwm
2. Kev tiv thaiv kab tiv thaiv kev tswj hwm lub tswv yim
Cov ntaub ntawv kuaj mob qhia tias hais txog 0. 03% ntawm cov neeg mob hom kev tsis haum tshuaj IV. Los ntawm kev sib tw galactose seem nyob rau saum npoo, cov ntsuas kev ua kom tiav tuaj yeem txo los ntawm 7.8% rau 1.2%. Lub tshuab tiv thaiv tshiab ua tshuab txo cov nyiaj ntawm fibrinogen adsorbed ntawm cov khoom saum npoo los ntawm 89%.
5. Ntxuav cov ntawv thov: Kev tswjfwm tshiab hauv cov cuab yeej kho mob thiab cov neeg nqa tshuaj
Cov Khaub Ncaws Ntses Hnav
Medtronic lub ntsiab kev hnav khaub ncaws hydrogel tshiab yuav txo cov kab mob hydrogel ntawm 12% mus rau 3% los ntawm kev ua haujlwm parsimicrobial peptides. Cov ntaub ntawv kuaj mob qhia tau tias kev kho kom zoo yog luv los ntawm nws nruab nrab ntawm 5.2 hnub.
Lub Hom Phiaj Tso Cai Siv Tshuaj
Lub siab-lub siab siv tshuaj yeeb-loaded tsom iav tsim los ntawm HlP-Poloxamer muaj kev npaj rau hauv lub siab mus rau 7 zaug uas npaj ua kom muaj txiaj ntsig los ntawm kev tsim nyog los ntawm 60%
6.future hloov zuj zus: kev coj ua txoj cai thiab kev sib xyaw ua ke
Kev lag luam thoob ntiaj teb yuav tsum tau mus txog peb $ 4.7 billion hauv 2025, nrog ib lub CAGR ntawm 8.7%. Cov kev cai EU tshiab yuav tsum cog cov ntaub ntawv los muab {5}} xyoo cov ntaub ntawv tsis muaj txiaj ntsig, tsav tsheb rau kev lag luam rau kev tswj kom meej. Kev tawg hauv nanoassembly technology ua rau nws ua tau kom hloov kho cov khoom siv, thiab thawj programmable biointerface cov khoom yuav tsum tau tshwm sim hauv 2030.
Cov ntaub ntawv nyob hauv tsab xov xwm no yog lub Ob Hlis 2025, thiab kev nce qib muaj kev cuam tshuam yog hloov tshiab tsis tu ncua.



